Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | TACR2 | P21452 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SHBG | P04278 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18531403 | 1.00 | CA2 (0.62) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL27828515 | 1.00 | CA2 (0.62) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL29184955 | 0.98 | CA2 (0.60) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL4686647 | 0.93 | CA2 (0.62) | CA2SMN1; SMN2LMNAALDH1A1HSD17B10 | |
| SCHEMBL11589672 | 0.88 | CA2 (0.64) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL2323376 | 0.88 | CA2 (0.64) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL11724457 | 0.87 | CA2 (0.58) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL29224601 | 0.85 | CA2 (0.65) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL13421994 | 0.85 | CA2 (0.60) | CA2SMN1; SMN2ESR1ADRA2AADORA3 | |
| SCHEMBL27611655 | 0.85 | CA2 (0.60) | CA2SMN1; SMN2ESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795266-B2 | Method for preparing a mixed silane-terminated polymer | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11572509-B2 | Ionic liquids formulation as an environmentally friendly oil dispersant | PETROLIAM NASIONAL BERHAD (MY) | 2023-02-07 | — | — | US | disclosed |
| US-20220032249-A1 | IONIC LIQUIDS FORMULATION AS AN ENVIRONMENTALLY FRIENDLY OIL DISPERSANT | PETROLIAM NASIONAL BERHAD (MY) | 2022-02-03 | — | — | US | disclosed |
| WO-2020060389-A1 | IONIC LIQUIDS FORMULATION AS AN ENVIRONMENTALLY FRIENDLY OIL DISPERSANT | PETROLIAM NASIONAL BERHAD (MY) | 2020-03-26 | — | — | WO | disclosed |
| US-9994744-B2 | Tin- and phthalate-free sealant based on silane terminated polymers | SIKA TECHNOLOGY AG (CH) | 2018-06-12 | — | — | US | disclosed |
| US-9630982-B2 | Colored charged silsesquioxanes | BASF SE (DE) | 2017-04-25 | — | — | US | disclosed |
| US-9630982-B2 | Colored charged silsesquioxanes | BASF SE (DE) | 2017-04-25 | — | — | US | disclosed |
| US-20170101564-A1 | TIN- AND PHTHALATE-FREE SEALANT BASED ON SILANE TERMINATED POLYMERS | SIKA TECHNOLOGY AG (CH) | 2017-04-13 | — | — | US | disclosed |
| US-20170101564-A1 | TIN- AND PHTHALATE-FREE SEALANT BASED ON SILANE TERMINATED POLYMERS | SIKA TECHNOLOGY AG (CH) | 2017-04-13 | — | — | US | disclosed |
| US-9580450-B2 | — | — | 2017-02-28 | — | — | US | disclosed |
| US-20090149668-A1 | Method for Producing Sodium Chloride-Free Ammonium Nitriles | CLARIANT INTERNATIONAL, LTD. (CH) | 2009-06-11 | — | — | US | disclosed |
| US-20090101644-A1 | Closure | SIKA TECHNOLOGY AG (CH) | 2009-04-23 | — | — | US | disclosed |
| US-20090093114-A1 | METHOD OF FORMING A DUAL-DAMASCENE STRUCTURE USING AN UNDERLAYER | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2009-04-09 | — | — | US | disclosed |
| US-20090068477-A1 | Method for Applying an Adhesion Promoter Composition by Means of an Ultrasonic Atomizer | SIKA TECHNOLOGY AG (CH) | 2009-03-12 | — | — | US | disclosed |
| US-20090025851-A1 | Use of Compositions for Removing Silicone Compounds | SIKA TECHNOLOGY AG (CH) | 2009-01-29 | — | — | US | disclosed |
| EP-2001836-A1 | IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES | CLARIANT INTERNATIONAL LTD. (CH) | 2008-12-17 | — | — | EP | disclosed |
| US-20080283425-A1 | Two-component adhesion promoter composition and use of packaging comprising two compartments | SIKA TECHNOLOGY AG (CH) | 2008-11-20 | — | — | US | disclosed |
| US-20080245271-A1 | Dividing wall; one compartment contains organsilicon, organotitanium and, or organozirconium compound; second compartment contains catalyst; for surface pretreatment | TRABESINGER GERALD | 2008-10-09 | — | — | US | disclosed |
| WO-2007110163-A1 | IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES | CLARIANT INTERNATIONAL LTD (CH) | 2007-10-04 | — | — | WO | disclosed |
| US-4310471-A | SURFACTANTS | EXXON RESEARCH & ENGINEERING CO. (US) | 1982-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149668-A1 | Method for Producing Sodium Chloride-Free Ammonium Nitriles | CBR3, CBR1, AKR1C3 | CA2 676/4885SMN1; SMN2 3631/4885ESR1 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.